Rounds / Neusignal Therapeutics
NT
Neusignal Therapeutics raises ¥5.32B (Series B)
- Company
- Neusignal Therapeutics
- Reported
- 3 Jul 2026 · that week's brief
- Stage
- Series B · 「シリーズB」 ·
- Amount
- ¥5.32B1 · as announced: 「総額53.2億円」
- Breakdown
- Equity ¥5.32B
- Registry
- Not checked against the registry yet
- Notes
- Checked on 17 Oct 2026 against the PR TIMES release (amount, instrument, investors).
- Investors
- Keio Innovation InitiativeNippon Venture CapitalAngel BridgeRed CapitalNissay CapitalGogin CapitalDCI Partners · list incomplete (release ends with 等/ほか)
- Sector
- Healthcare
- Source
- Release (PR TIMES; no announcement found on the company's own site yet) · News coverage
1 ≈ ~$33M at the ECB reference rate on 2026-07-03 (¥1 = $0.00621). Yen is the figure of record. Methodology
Get the weekly brief
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →